about
Impact of Diet-Induced Obesity and Testosterone Deficiency on the Cardiovascular System: A Novel Rodent Model Representative of Males with Testosterone-Deficient Metabolic Syndrome (TDMetS)Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationRemote ischaemic preconditioning for coronary artery bypass grafting (with or without valve surgery).Diabetic cardiomyopathy: pathophysiology and clinical featuresIs there a role for ischaemic conditioning in cardiac surgery?Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations.Remote ischemic conditioning.The challenge of translating ischemic conditioning from animal models to humans: the role of comorbidities.Cardiovascular remodelling in coronary artery disease and heart failure.The diabetic heart: too sweet for its own good?Differences in myocardial PTEN expression and Akt signalling in type 2 diabetic and nondiabetic patients undergoing coronary bypass surgeryEffects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.Remote ischaemic conditioning: cardiac protection from afar.Impact of O-GlcNAc on cardioprotection by remote ischaemic preconditioning in non-diabetic and diabetic patients.Assessment of Risk Factors in Patients With Myocardial InfarctionRole of phosphoinositide 3-kinase IA (PI3K-IA) activation in cardioprotection induced by ouabain preconditioningCardioprotection in the aging, diabetic heart: the loss of protective Akt signalling.The Akt1 isoform is an essential mediator of ischaemic preconditioningInsulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanisms.A role for GRK2 in myocardial ischemic injury: indicators of a potential future therapy and diagnostic.Autophagy, myocardial protection, and the metabolic syndrome.Oxidative stress and myocardial injury in the diabetic heartTranslating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology.Molecular mechanisms of ischemic conditioning: translation into patient outcomes.The role of post-translational modifications in acute and chronic cardiovascular disease.Remote ischaemic conditioning-a new paradigm of self-protection in the brain.Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.The role of PI3Kα isoform in cardioprotection.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.The RISK pathway and beyond.Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non-diabetic exosomes in vitro.Glimepiride treatment facilitates ischemic preconditioning in the diabetic heart.Mitochondrial and Contractile Function of Human Right Atrial Tissue in Response to Remote Ischemic ConditioningModels of Ischemia-Reperfusion Injury
P2860
Q27318055-706D4298-457E-4B39-A92C-5A300AFAE832Q28072918-D429C194-F767-4736-B684-A27BA83907FCQ28078462-FCEF3A26-2067-4649-93E0-1EC960195260Q30234557-98F0F784-9D7E-48C2-9D62-8C5BAECD7461Q30457504-1C82EAC2-5716-4A23-8213-A5A4C8FFD699Q33605260-F83E4205-6602-4F53-84C1-E70BC913F265Q34247485-33CB434B-099D-4953-A65E-02036AE9465EQ34458416-3E52C796-D5B0-4C18-A14E-CB1597A5B346Q34637342-F9F23994-EB20-4329-BAE9-94417C7BC0C1Q35090566-53CDD06C-07AD-42F6-AD23-384BCBD3375CQ35810679-AE2C7B85-9C05-4F09-BC1E-CCC624D0C0C7Q36043779-A09B889E-22F3-4A99-A53D-8349AAA937A5Q36288965-E63A8AE4-F239-48B2-8A6C-D0AE49245EFFQ36532517-48D20F3C-B007-4C10-8A1C-DBCE6CB69779Q36647017-F64AF040-D466-4247-85E2-C70FD4421809Q36718879-6CF4B2F3-22B7-46E7-B9EE-3DE87EEB953AQ36787700-28AE4CD1-EFC3-4F06-90F8-DF1FD684872EQ37104169-6A4381CF-D070-4347-8A92-EAD7D95ED694Q37294231-F61A6706-9261-4CBF-B19B-5A62FD22E5F7Q37330288-19FE1423-E0DC-41AB-B9EE-2C879DA38340Q37907329-902AAD12-4291-4729-9087-30978AC4E159Q37999635-39D7B8E6-9DAA-4305-B0B5-BF23C3A28188Q38046547-26D76AE5-D980-4FA1-90DB-15D7151965E2Q38075417-AAF6D8C0-4632-42A0-AE03-0B006D0F1489Q38120093-82DBBA12-5FD2-4A0E-96F7-C5ABA9833518Q38222880-500782A3-4D6D-4230-A290-FC3F5916D0D4Q38639332-E1B6D005-268A-441F-A965-2536E1F9179DQ41741312-A082B1CE-4C0D-4971-BE6B-E9AEDC281B50Q42683501-6ACD3EB4-6D10-45ED-A668-DE3EA5620823Q46034115-4C4A419C-DA5B-40A5-923B-CFB391F1AE53Q47100578-245A117F-8480-4D6D-8B33-221383D21F3CQ47109033-8D1D3471-E801-4A47-BC02-5D3022924ADFQ54463866-16D47C0F-FA52-4663-B3E9-AB6A2D3F59FCQ58130076-97273247-4602-4902-A0E8-CC59141E1D38Q58561894-38D8A317-296F-4126-BA53-ACA57273786A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preconditioning the diabetic human myocardium
@en
Preconditioning the diabetic human myocardium.
@nl
type
label
Preconditioning the diabetic human myocardium
@en
Preconditioning the diabetic human myocardium.
@nl
prefLabel
Preconditioning the diabetic human myocardium
@en
Preconditioning the diabetic human myocardium.
@nl
P2860
P1476
Preconditioning the diabetic human myocardium
@en
P2093
Abigail M Wynne
Vivek Sivaraman
P2860
P304
P356
10.1111/J.1582-4934.2009.00796.X
P577
2009-06-05T00:00:00Z